Legal Representation
Attorney
Roy D. Gross
USPTO Deadlines
Next Deadline
886 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-04)
Due Date
January 04, 2028
Grace Period Ends
July 04, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 30, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 29, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 8, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 8, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 20, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 20, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 20, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 23, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 23, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 3, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 15, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 15, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 15, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 15, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 15, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 8, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicated lozenge; Medicated lozenge, namely, a ultra-absorbable turmeric based mentholyptus flavored, all natural lozenge; Lozenge, namely, cough and throat lozenges; tablets and medical tablets for treating sore throats or throat disorders; drug delivery agents in the form of tablets that provide controlled release of active ingredients for a wide variety of pharmaceuticals; drug delivery agents, namely, compounds that facilitate delivery of a wide range of pharmaceuticals; nutritional supplements
First Use Anywhere:
Jul 31, 2021
First Use in Commerce:
Jul 31, 2021
Classification
International Classes
005